Castle Biosciences, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mesa Laboratories, Inc.

Artivion, Inc.

IRadimed Corp.

BioLife Solutions, Inc.

Outset Medical, Inc.

Orthofix Medical, Inc.

Silk Road Medical, Inc.

Castle Biosciences, Inc.

Atrion Corp.

Nevro Corp.

Minerva Surgical, Inc.

Why is Castle Biosciences, Inc. ?

The company has declared negative results in Mar'2025 after 7 consecutive positive quarters

PRE-TAX PROFIT(Q) At USD -3.95 MM has Fallen at -147.66%
NET PROFIT(Q) At USD -4.06 MM has Fallen at -279.02%
RAW MATERIAL COST(Y) Grown by 5.78% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 33.90%, its profits have fallen by -365%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Castle Biosciences, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Castle Biosciences, Inc.

33.9%

0.18

63.21%

S&P 500

18.81%

0.98

19.26%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

40.39%

EBIT Growth (5y)

-301.27%

EBIT to Interest (avg)

-44.30

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.60

Sales to Capital Employed (avg)

0.64

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.64

EV to EBIT

-14.08

EV to EBITDA

62.83

EV to Capital Employed

2.58

EV to Sales

1.43

PEG Ratio

Dividend Yield

ROCE (Latest)

-18.29%

ROE (Latest)

-3.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 68.46 MM

NET PROFIT(HY)

Higher at USD -0.72 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 14.18 times

-18What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -3.95 MM has Fallen at -147.66%

NET PROFIT(Q)

At USD -4.06 MM has Fallen at -279.02%

RAW MATERIAL COST(Y)

Grown by 5.78% (YoY

NET SALES(Q)

Lowest at USD 83.04 MM

OPERATING PROFIT(Q)

Lowest at USD -2.99 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -3.6 %

Here's what is working for Castle Biosciences, Inc.

Operating Cash Flow

Highest at USD 68.46 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Highest at 14.18 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Castle Biosciences, Inc.

Pre-Tax Profit

At USD -3.95 MM has Fallen at -147.66%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -4.06 MM has Fallen at -279.02%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

Lowest at USD 83.04 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit

Lowest at USD -2.99 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at -3.6 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost

Grown by 5.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales